The FDA’s Center for Devices and Radiological Health (CDRH) announced the release of its 2024 safety and innovation reports, which underscore the Center’s proactive measures in updating the 2018 Medical Device Safety Action Plan and regulating the advancements in technology while fostering a more innovative landscape for device manufacturers in the United States.
The CDRH 2024 Safety Report serves as a comprehensive update to the 2018 Medical Device Safety Action Plan, highlighting the strides taken in recent years to ensure that the safety standards for medical devices remain aligned with the rapid evolution of technology. Concurrently, the CDRH 2024 Innovation Report showcases our endeavors to foster innovation and outlines the strides made to enhance the appeal of the U.S. market for leading device developers.
Key initiatives addressed in the Safety Report include measures to bolster manufacturing quality, fortify post-market surveillance mechanisms, enhance data transparency, strengthen medical device recall procedures, and implement the agency’s medical device safety action plan. Simultaneously, the release of the 2024 Innovation Report aligns with efforts to stimulate innovation, expand regulatory flexibility, engage with patients and stakeholders, and foster collaboration with innovators.
Through these collective endeavors detailed in the 2024 Safety and Innovation reports, CDRH reaffirms its unwavering commitment to advancing its mission of safeguarding and enhancing public health.
These reports summarize FDA’s accomplishments and look ahead to future initiatives.
Read the CDRH Safety Report here.
Read the CDRH Innovation Report here.
